nitric oxide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-06-21. Anything still debated is marked as such rather than presented as settled.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
| Property | Value | Notes |
|---|---|---|
| Typical subjects | Rats and mice | Animal models |
| Common routes | Injection and oral | Route varies by study |
| Reported dose range | Microgram to milligram per kg | Not standardized across work |
| Frequent endpoints | Tissue repair, angiogenesis | Marker-dependent |
| Human evidence | Limited | Mostly small or preliminary studies |
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
Peptides are susceptible to hydrolysis, oxidation, and aggregation, and BPC-157 is no exception. The lyophilized powder form is generally more stable than a solution because residual moisture is low and molecular mobility is reduced. Once dissolved, the peptide is exposed to water, oxygen, and trace metal ions that accelerate degradation. Light exposure and repeated freeze-thaw cycles are also commonly cited as sources of loss. These general principles guide most handling recommendations found in supplier documentation.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
In the case of air pumps, diaphragm pumps are considered to be a type of pump that utilizes positive displacement. A simple diaphragm pump contains a chamber that acts like a springy diaphragm. When compressed, the air within the diaphragm gets expelled. When the diaphragm is decompressed, the chamber refills with air. A simple example for a diaphragm pump is a foot pump that requires the user to constantly step up and down on the pump to inflate something. Engine-driven tire pump Several companies developed engine-driven tire pumps in the brass era of the automobile. Reciprocating Pumps
== Uses == BPF is used in the manufacture of plastics and epoxy resins. It is used in the production of tank and pipe linings, industrial flooring, road and bridge deck toppings, structural adhesives, grouts, coatings and electrical varnishes. BPF is also utilized in liners, lacquers, adhesives, plastics, and the coating of drinks and food cans. BPF is found in dental materials, such as restorative materials, liners, adhesives, oral prosthetic devices and tissue substitutes.
After the Iraqi government was overthrown in the 2003 invasion of Iraq, Galloway defended Iraqi insurgents targeting Western forces. In August 2005, he praised them as "martyrs", condemned Iraqis who worked with the new security forces as "collaborators" and said it was "normal" for them to be the targets of suicide bombers. He said: "These poor Iraqis – ragged people, with their sandals, with their Kalashnikovs, with the lightest and most basic of weapons – are writing the names of their cities and towns in the stars, with 145 military operations every day, which has made the country ungovernable. We don't know who they are, we don't know their names, we never saw their faces, they don't put up photographs of their martyrs, we don't know the names of their leaders". Galloway was challenged by the BBC but denied making the "martyrs" comment. Concerning the Iraq War, he said he would not rest "until Tony Blair is brought to justice", and in 2019 announced plans to try to prosecute Alastair Campbell.
Low-end restaurants and street vendors are the biggest end users of gutter oil, as they operate with lower profit margins than bigger restaurants. Oil is a large kitchen supply cost for some restaurants, so obtaining cheaper oil can allow a marginal restaurant to reduce its overall expenses. Chinese food is generally heavily dependent on oil due to most foods being fried, so cheaper meal prices for many price-sensitive consumers are possible if gutter oil is used instead of virgin oil. The situation becomes more serious because it is hard to distinguish reprocessed gutter oil from legitimate oil. Bleach is used to transform gutter oil's dark color into a more natural-looking one, and alkali additives are used to neutralize the abnormal pH caused by high concentrations of animal fats. Used kitchen oil can be purchased for between US$859 and US$937 per ton, while the cleaned and refined product can sell for US$1,560 per ton. Thus there is great economic incentive to produce and sell gutter oil.
Sources: en.wikipedia.org
==== Distribution of fitness effects (DFE) ==== Attempts have been made to infer the distribution of fitness effects (DFE) using mutagenesis experiments and theoretical models applied to molecular sequence data. DFE, as used to determine the relative abundance of different types of mutations (i.e., strongly deleterious, nearly neutral or advantageous), is relevant to many evolutionary questions, such as the maintenance of genetic variation, the rate of genomic decay, the maintenance of outcrossing sexual reproduction as opposed to inbreeding and the evolution of sex and genetic recombination. DFE can also be tracked by tracking the skewness of the distribution of mutations with putatively severe effects as compared to the distribution of mutations with putatively mild or absent effect. In summary, the DFE plays an important role in predicting evolutionary dynamics. A variety of approaches have been used to study the DFE, including theoretical, experimental and analytical methods.
== Description == Bryant Park is located between Fifth and Sixth Avenues and between 40th and 42nd Streets, and covers 9.6 acres (3.9 ha). Although technically the main branch of the New York Public Library is located within the park, in design it forms the eastern boundary of the park's green space, making Sixth Avenue the park's primary entrance. Bryant Park is used mostly as a passive recreation space, and lacks active sports facilities. Bryant Park is several steps above the surrounding streets, enclosed by a retaining wall. Granite stairs at several locations provide access from the surrounding sidewalks. The surrounding area contains numerous structures, including the Bank of America Tower and 1095 Avenue of the Americas to the northwest; the Bryant Park Studios, American Radiator Building, Engineers' Club Building, and 452 Fifth Avenue to the south; 461 Fifth Avenue and the Stavros Niarchos Foundation Library to the southeast; and 500 Fifth Avenue, the Aeolian Building, and the W.R. Grace Building to the north. One of the park's largest features is a large lawn located slightly below the level of the surrounding walkways. Besides serving as a "lunchroom" for office workers, the lawn serves as the seating area for some of the park's major events, such as Bryant Park Movie Nights, Broadway in Bryant Park, and Square Dance. The lawn's season runs from February until October, when it is closed to make way for Bank of America Winter Village. Numerous walkways surround the central lawn. The northern and southern sides are each flanked by two flagstone walkways.
He worked on proteases, but is best known for his influential book General Biochemistry, written with his wife Sofia Simmonds, and for later work on the history of biochemistry. Member Natl. Acad. Sci. USA. Kazimierz Funk (1884–1967). Polish-American biochemist at the Pasteur Institute, discoverer of vitamin B3 (niacin). Robert F. Furchgott (1916–2009). American biochemist at the State University of New York known for discovering the biological roles of nitric oxide. Nobel Prize in Physiology or Medicine (1998). Member Natl. Acad. Sci. USA.
=== Luminous flux: watt equivalent === With the phaseout of the incandescent lamp in the United States and European Union in the early 21st century, manufacturers and sellers of more energy-efficient lamps have compared the visible light output of their lamps to commonly used incandescent lamp sizes with the watt equivalent or watt incandescent replacement (usually with a lowercase w as a unit symbol, as opposed to capital W for the actual wattage). 1 watt incandescent replacement corresponds to 15 lumens. Thus, a 72-watt halogen lamp, a 23-watt compact fluorescent lamp and a 14-watt light-emitting diode lamp, all of which emit 1500 lumens of visible light, are all marketed as "100 watt incandescent replacement" (100w).
== Prognosis == How well a patient does depends on the location of the clot and to what extent the clot has blocked blood flow. Arterial embolism can be serious if not treated promptly. Without treatment, it has a 25% to 30% mortality rate. The affected area can be permanently damaged, and up to approximately 25% of cases require amputation of an affected extremity. Arterial emboli may recur even after successful treatment.
Sources: en.wikipedia.org
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.
Frequently measured outcomes include wound healing, blood vessel growth, and tissue repair markers. Some work examines gastrointestinal protection. The choice of endpoint depends on the model used.
Different routes of administration and different animal models require different amounts. Studies also use varied timelines and measurement methods. This variation makes it difficult to combine results into a single standardized figure.
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.